newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Gross profit percentage of 36% for the quarter, up 1% from first fiscal quarter 2024Total operating expenses decreased for the quarter and six months ended September 30, 2023 compared to same period prior yearEuropean